Ausgabe 9/2008
Inhalt (29 Artikel)
Is a nutritional therapeutic approach unsuitable for metabolically healthy but obese women?
G. Perseghin
Is blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy?
D. N. Sang, P. A. D’Amore
Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
R. Simó, C. Hernández
Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus
R. Djaberi, E. D. Beishuizen, A. M. Pereira, T. J. Rabelink, J. W. Smit, J. T. Tamsma, M. V. Huisman, J. W. Jukema
Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries
T. Danne, T. Battelino, P. Jarosz-Chobot, O. Kordonouri, E. Pánkowska, J. Ludvigsson, E. Schober, E. Kaprio, T. Saukkonen, M. Nicolino, N. Tubiana-Rufi, C. Klinkert, H. Haberland, A. Vazeou, L. Madacsy, D. Zangen, V. Cherubini, I. Rabbone, S. Toni, C. de Beaufort, W. Bakker-van Waarde, N. van den Berg, I. Volkov, R. Barrio, R. Hanas, U. Zumsteg, B. Kuhlmann, C. Aebi, U. Schumacher, S. Gschwend, P. Hindmarsh, M. Torres, N. Shehadeh, M. Phillip
A novel insulin formulation with a more rapid onset of action
S. Steiner, M. Hompesch, R. Pohl, P. Simms, F. Flacke, T. Mohr, A. Pfützner, L. Heinemann
Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of Carbohydrates in Diabetes): a randomised controlled trial
T. M. S. Wolever, C. Mehling, J.-L. Chiasson, R. G. Josse, L. A. Leiter, P. Maheux, R. Rabasa-Lhoret, N. W. Rodger, E. A. Ryan
A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: results of a quasi-randomised controlled trial
A. Fraser, R. Abel, D. A. Lawlor, D. Fraser, A. Elhayany
Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes
H. Elding Larsson, G. Hansson, A. Carlsson, E. Cederwall, B. Jonsson, B. Jönsson, K. Larsson, K. Lynch, J. Neiderud, Å. Lernmark, S.-A. Ivarsson
Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study
J. W. J. Beulens, J. S. Kruidhof, D. E. Grobbee, N. Chaturvedi, J. H. Fuller, S. S. Soedamah-Muthu
Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database
H. E. Mulnier, H. E. Seaman, V. S. Raleigh, S. S. Soedamah-Muthu, H. M. Colhoun, R. A. Lawrenson, C. S. de Vries
Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation
T. Sparsø, G. Andersen, A. Albrechtsen, T. Jørgensen, K. Borch-Johnsen, A. Sandbæk, T. Lauritzen, J. Wasson, M. A. Permutt, B. Glaser, S. Madsbad, O. Pedersen, T. Hansen
Study of the association between the CAPSL-IL7R locus and type 1 diabetes
J. L. Santiago, B. Z. Alizadeh, A. Martínez, L. Espino, H. de la Calle, M. Fernández-Arquero, M. A. Figueredo, E. G. de la Concha, B. O. Roep, B. P. C. Koeleman, E. Urcelay
Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps
M. J. Groenewoud, J. M. Dekker, A. Fritsche, E. Reiling, G. Nijpels, R. J. Heine, J. A. Maassen, F. Machicao, S. A. Schäfer, H. U. Häring, L. M. ’t Hart, T. W. van Haeften
Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case–control study
P. Massin, D. Dubois-Laforgue, T. Meas, M. Laloi-Michelin, H. Gin, B. Bauduceau, C. Bellanné-Chantelot, E. Bertin, J.-F. Blickle, B. Bouhanick, J. Cahen-Varsaux, S. Casanova, G. Charpentier, P. Chedin, O. Dupuy, A. Grimaldi, B. Guerci, E. Kaloustian, A. Lecleire-Collet, F. Lorenzini, A. Murat, H. Narbonne, F. Olivier, V. Paquis-Flucklinger, M. Virally, M. Vincenot, B. Vialettes, J. Timsit, P. J. Guillausseau
Differentiation of mouse nuclear transfer embryonic stem cells into functional pancreatic beta cells
W. Jiang, Z. Bai, D. Zhang, Y. Shi, J. Yong, S. Chen, M. Ding, H. Deng
Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis
H. F. Irving-Rodgers, A. F. Ziolkowski, C. R. Parish, Y. Sado, Y. Ninomiya, C. J. Simeonovic, R. J. Rodgers
Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon
S. C. Collins, A. Salehi, L. Eliasson, C. S. Olofsson, P. Rorsman
Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?
P. Schrauwen, M. K. C. Hesselink
Increased fat:carbohydrate oxidation ratio in Il1ra −/− mice on a high-fat diet is associated with increased sympathetic tone
D. Chida, O. Hashimoto, M. Kuwahara, H. Sagara, T. Osaka, H. Tsubone, Y. Iwakura
The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes
R. Amin, J. Frystyk, K. Ong, R. N. Dalton, A. Flyvbjerg, D. B. Dunger
Performance of the revised ‘175’ Modification of Diet in Renal Disease equation in patients with type 2 diabetes
R. A. Chudleigh, R. L. Ollerton, G. Dunseath, R. Peter, J. N. Harvey, S. Luzio, D. R. Owens
Ethnic differences in retinal microvascular structure
T. Tillin, R. M. Evans, N. W. Witt, P. S. Sharp, P. M. McKeigue, N. Chaturvedi, A. D. Hughes
Evaluation of N ε-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy
X. Zhang, Y. Lai, D. R. McCance, K. Uchida, D. M. McDonald, T. A. Gardiner, A. W. Stitt, T. M. Curtis
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
A. C. Calkin, S. Giunti, K. J. Sheehy, C. Chew, V. Boolell, Y. S. Rajaram, M. E. Cooper, K. A. Jandeleit-Dahm
A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-β activation in the kidneys of rats used as a model of diabetes
D. Gong, J. Lu, X. Chen, S. Reddy, D. J. Crossman, S. Glyn-Jones, Y.-S. Choong, J. Kennedy, B. Barry, S. Zhang, Y.-K. Chan, K. Ruggiero, A. R. J. Phillips, G. J. S. Cooper
Metabolically healthy but obese women: effect of an energy-restricted diet
A. D. Karelis, V. Messier, M. Brochu, R. Rabasa-Lhoret
Resistance exercise and control of cerebral blood flow in type 2 diabetes
Y. S. Kim, N. H. Secher, J. J. van Lieshout